FDA Approved: ZUSDURI — Original Application (UroGen Pharma, Inc)

View source ↗

Summary

FDA approves ZUSDURI (mitomycin) from UroGen Pharma under an original NDA, marking its first approval for use in bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• ZUSDURI (Mitomycin)

Snippet

ORIG AP for ZUSDURI (MITOMYCIN)